Shares of Milestone Therapeutics MIST fell 21.67% during market hours on Oct 17, after rising 41% in premarket, post the company’s announcement of top-line results from a late-stage study evaluating ...

In the largest genome study to date, a team led by scientists at the University of Queensland (UQ) has analyzed genetic data of nearly 5.4 million people from 281 genome-wide association studies (GWAS ...

The PDUFA date for CARDAMYST™ is set for March 27, 2025, indicating a lengthy approval timeline that could delay commercialization and revenue generation for the company. The reliance on the FDA's ...